develops breakthrough technologies that deliver interventional intelligence in healthcare, improving the understanding, design, evaluation, and delivery of treatments.

Our approach is powered by multi-modal generative AI models that capture the complexity of biological systems—especially the brain—with precision that other methods cannot match.

Learning from large-scale, real-world, clinical and investigational data, we create precise models of disease biology (Large Medicine Models) that help us understand individual differences at an unprecedented level of detail.

Our technology enhances drug development, particularly in the critical late stages, by uncovering hidden treatment effects that are often missed owing to biological complexity. Without models sophisticated enough to capture this detail, even highly effective treatments risk failing in trials.

Combined with a flexible, anatomically targeted, multi-agent therapeutic platform, our approach allows us to craft intelligent, personalised interventions for both common and rare neurological disorders.

We deploy this technology within novel commercial structures that accelerate its real-world translation and maximise its value to patients and creators.

Drawing on a unique cross-disciplinary team and a decade of cutting-edge research, is a radically new kind of business for the emerging age of AI-enabled healthcare.